Management of Blood Pressure in Bilateral Renal Artery Stenosis

First-Line Medication Options

• The American College of Cardiology recommends calcium channel blockers, such as amlodipine, as first-line therapy for hypertension in bilateral renal artery stenosis due to their effectiveness in lowering blood pressure without compromising renal perfusion 1

Medications to Avoid or Use with Caution

• The European Society of Cardiology and the Kidney International society recommend that ACE inhibitors and ARBs should generally be avoided in patients with bilateral renal artery stenosis or unilateral stenosis in a solitary functioning kidney, as they can cause acute renal failure 2, 3
• If RAS blockers are deemed necessary due to compelling indications, they should only be initiated with extremely close monitoring of renal function, according to the Kidney International society 3

Special Considerations for Medical Management

• The Kidney International society recommends that antiplatelet therapy should be part of the management regimen to reduce cardiovascular risk 3, 1
• High-dose statin therapy is essential for patients with bilateral renal artery stenosis, as they have high cardiovascular risk, according to the Kidney International society 3
• Blood pressure targets should follow standard hypertension guidelines, aiming for <140/90 mmHg in most patients, as recommended by the European Society of Cardiology 4

Indications for Revascularization

• Revascularization should be considered in patients with bilateral renal artery stenosis when medical therapy fails to control blood pressure adequately, according to the American Heart Association and the Hypertension society 5, 6
• The Kidney International society recommends revascularization in cases of progressive decline in renal function or recurrent episodes of flash pulmonary edema or heart failure despite optimal medical therapy 3, 6

Revascularization Approaches

• The European Society of Cardiology recommends renal artery angioplasty with stenting as the preferred approach for atherosclerotic disease, which accounts for 90% of cases 2, 1
• For fibromuscular dysplasia, balloon angioplasty without stenting is recommended, according to the European Society of Cardiology 2, 4

Post-Revascularization Management

• The Kidney International society and the Praxis Medical Insights society recommend continuing antiplatelet therapy and statins post-revascularization 3, 1
• Regular follow-up with blood pressure monitoring and renal function assessment is essential, according to the Praxis Medical Insights society 1

Common Pitfalls and Caveats

• Failure to recognize bilateral renal artery stenosis in patients with resistant hypertension or unexplained renal dysfunction can lead to delayed diagnosis and treatment, as noted by the Hypertension society 5
• Inappropriate use of ACE inhibitors or ARBs can lead to acute kidney injury, according to the European Society of Cardiology 2
• Delaying revascularization in appropriate candidates can lead to irreversible kidney damage, as warned by the Kidney International society and the Circulation society 3, 6